(Los Angeles, CA) – Actor Kazy Tauginas (“The Equalizer 2”) has announced today that he will be participating in the Walk to End Lupus Now® event organized by the Lupus Foundation of America. The event will take place in Los Angeles on Saturday, September 22nd, bringing communities together to raise money for lupus research, increase awareness, and rally public support for those who suffer from the life-threatening disease.
Mesh devices may be to blame for autoimmune symptoms
The news comes from a rheumatologist from the University of Alberta who believes that symptoms such as chronic fatigue, cognitive impairments and muscle pain can be linked to patients who have been implanted with mesh devices.
Jan Willem Cohen Tervaert, director of the Division of Rheumatology explains.
“In my practice, I studied 40 patients who had mesh implants and found that almost all of them had symptoms such as chronic fatigue, cognitive impairment known as “brain fog,” muscle and joint pain “fibromyalgia,” feverish temperature, and dry eyes and dry mouth,” Tervaert said.
Model Robyn Lawley reveals her shocking injuries after having a seizure and falling down the stairs
Model Robyn Lawley has shared shocking photographs of the injuries she suffered following a horrific fall down a set of stairs, earlier this year.
The 29-year-old, who was diagnosed with Lupus in 2015, had a seizure nearly two months ago, falling seven feet down the staircase at her New York home, landing on her face.
Pediatric Lupus: Different than in Adults
Young adults with SLE experience 20% to 40% work loss rate
On the 70th anniversary of the NHS coming into action, Seal has opened up on his battle with Lupus.
Son of former President of South Africa Jacob Zuma dies from lupus
The U.S. Food and Drug Administration (FDA) has approved new automated diagnostic tests for lupus and ANCA-associated vasculitis
The U.S. Food and Drug Administration (FDA) has approved new automated diagnostic tests for lupus and ANCA-associated vasculitis, a form of blood vessel inflammation, Grifols, which will market these tests, announced.